Summary
Pete Lally is a Magnetic Resonance (MR) physicist in Bioengineering, and both a Sir Henry Wellcome Postdoctoral Fellow and Edmond and Lily Safra Fellow.
He obtained his PhD at Imperial College London, developing MR spectroscopy techniques for application in the neonatal brain in the initial weeks following perinatal hypoxic-ischaemic injury.
He is now developing MRI techniques for rapid, high-resolution brain imaging, with a particular focus on neurodegenerative disease at 3T (Hammersmith Hospital) and at 7T (LoCUS).
Publications
Journals
Thayyil S, Montaldo P, Krishnan V, et al., 2023, Whole-body hypothermia, cerebral magnetic resonance biomarkers, and outcomes in neonates with moderate or severe hypoxic-ischemic encephalopathy born at tertiary care centers vs other facilities: a nested study within a randomized clinical trial, Jama Network Open, Vol:6, ISSN:2574-3805, Pages:1-16
Sveinsson B, Rowe OE, Stockmann JP, et al., 2022, Feasibility of simultaneous high-resolution anatomical and quantitative magnetic resonance imaging of sciatic nerves in patients with Charcot-Marie-Tooth type 1A (CMT1A) at 7T, Muscle and Nerve, Vol:66, ISSN:0148-639X, Pages:206-211
Song Y, Lally PJ, Lopez MY, et al., 2022, Edited magnetic resonance spectroscopy in the neonatal brain, Neuroradiology: a Journal Devoted to Neuroimaging and Interventional Neuroradiology, Vol:64, ISSN:0028-3940, Pages:217-232
Evans M, Wade C, Hohenschurz-Schmidt D, et al., 2021, Magnetic resonance imaging as a biomarker in diabetic and HIV-associated peripheral neuropathy: A systematic review-based narrative, Frontiers in Neuroscience, Vol:15, ISSN:1662-453X
Thayyil S, Pant S, Montaldo P, et al., 2021, Hypothermia for moderate or severe neonatal encephalopathy in low and middle-income countries (HELIX): a randomised control trial in India, Sri Lanka and Bangladesh, The Lancet Global Health, Vol:9, ISSN:2214-109X, Pages:e1273-e1285